Therapeutic effect of methylprednisolone on acute lipogenic pancreatitis

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300069365

Enrollment

Unknown

Registered

2023-03-14

Start date

2022-09-01

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute lipogenic pancreatitis

Interventions

Experimental group:methylprednisolone

control group:none

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 18-65 years old, diagnosed with acute pancreatitis, triglyceride >= 11.3mmol/L.

Exclusion criteria

Exclusion criteria: Contraindications to hormones.

Design outcomes

Primary

Measure	Time frame
ICU occupancy rate or proportion of severe acute pancreatitis or mortality rate;	—

Secondary

Measure	Time frame
hospitalization cost;Abdominal pain duration;Incidence of gastrointestinal bleeding;	—

Countries

China

Contacts

Public ContactZhou Jinggang

Jiangyou People's Hospital

2515076560@qq.com+86 13990158662

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026